---
title: "LLNL Nerve Agent Antidote Shows Great Potential"
description: "CBRNe World provides those tasked with defending against CBRN and IED threats with the essential practical, scientific and political information. Access the current and previous issues of the magazine by registering as a member."
url: "https://cbrneworld.com/news/subscribers/llnl-nerve-agent-antidote-shows-great-potential"
date: "2026-07-30T21:09:12+00:00"
language: "en-GB"
---

![](https://cbrneworld.com/component/ajax/?p=image&src=%7B%22file%22%3A%22images%2FNews-Images%2Fsyringe-417786_640.jpg%22%2C%22thumbnail%22%3A%22%2C%22%7D&hash=6278692f)

#  LLNL Nerve Agent Antidote Shows Great Potential

 Written by Zoe Rutherford on 17 September 2019.

Scientists at the Lawrence Livermore National Laboratory have been working with live agent, supercomputers, and accelerated mass spectrometry, to develop a new nerve agent antidote, namely LLNL-02.

Their work has been showing great promise, and with somw refinement of the LLNL-02 antidote and identifying a second potential candidate molecule, they are working towards approval of LLNL-02 by the FDA.

You can read all about the work thay have beem doing, and how in [this research highlight article from LLNL. ](https://str.llnl.gov/2019-06/valdez)

 [CBRNe](https://cbrneworld.com/component/tags/tag/cbrne), [Chemical](https://cbrneworld.com/component/tags/tag/chemical), [Protection](https://cbrneworld.com/component/tags/tag/protection), [R&D](https://cbrneworld.com/component/tags/tag/r-d)

## Schema

```json
{ "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "News", "item": "https://cbrneworld.com/news" }, { "@type": "ListItem", "position": 2, "name": "Subscribers", "item": "https://cbrneworld.com/news/subscribers" }, { "@type": "ListItem", "position": 3, "name": "LLNL Nerve Agent Antidote Shows Great Potential", "item": "https://cbrneworld.com/news/subscribers/llnl-nerve-agent-antidote-shows-great-potential" } ] }
```

```json
{ "@context": "https://schema.org", "@type": "NewsArticle", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://cbrneworld.com/news/subscribers/llnl-nerve-agent-antidote-shows-great-potential" }, "headline": "LLNL Nerve Agent Antidote Shows Great Potential", "description": "Scientists at the Lawrence Livermore National Laboratory have been working with live agent, supercomputers, and accelerated mass spectrometry, to develop a new nerve agent antidote, namely LLNL-02.  Their work has been showing great promise, and with somw refinement of the LLNL-02 antidote and identifying a second potential candidate molecule, they are working towards approval of LLNL-02 by the FDA.  You can read all about the work thay have beem doing, and how in this research highlight article from LLNL. ", "image": { "@type": "ImageObject", "url": "https://cbrneworld.com/images/News-Images/syringe-417786_640.jpg" }, "publisher": { "@type": "Organization", "name": "CBRNe World Magazine", "logo": { "@type": "ImageObject", "url": "https://cbrneworld.com/images/default/Asset%201.png" } }, "author": { "@type": "Person", "name": "Zoe Rutherford", "url": "https://cbrneworld.com/news/subscribers/llnl-nerve-agent-antidote-shows-great-potential" }, "datePublished": "2019-09-17T11:02:05+01:00", "dateCreated": "2019-09-17T11:02:05+01:00", "dateModified": "2019-09-17T11:02:05+01:00" }
```